|
Press Releases |
|
 |
|
Tuesday, August 27, 2024 |
|
First Results From Lexaria's Second GLP-1 Human Pilot Study |
more info >> |
|
Thursday, August 22, 2024 |
|
Positive 8-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study |
Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that it has received and can now report on 8-week body weight results from ongoing animal study WEIGHT-A24-1 (the "Study"). more info >> |
|
Wednesday, August 21, 2024 |
|
Positive Interim Blood Sugar Results From Lexaria's GLP-1 Diabetes Animal Study |
Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that it has received 4-week and 8-week blood glucose results from ongoing animal study WEIGHT-A24-1 (the "Study"). more info >> |
|
Monday, August 19, 2024 |
|
Positive Results from Lexaria's Molecular Characterization Study Monomeric form of GLP-1 drug preserved by DehydraTECH |
Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces positive findings from its applied research program together with the National Research Council of Canada ("NRC") that evaluated important mode of action facets of DehydraTECH processed with the glucagon-peptide 1 ("GLP-1") drug, semaglutide. more info >> |
|
Monday, July 8, 2024 |
|
Lexaria Receives New Patents For Antiviral Drug Delivery and for Treating Epilepsy |
Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces three new patent awards. more info >> |
|
Wednesday, May 8, 2024 |
|
Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study |
Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that human pilot study #2, GLP-1-H24-2, (the "Study") is underway and the first dosing visit for all nine study participants has already concluded. more info >> |
|
Monday, May 6, 2024 |
|
Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 Drugs |
Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces an applied research program to evaluate certain molecular characteristics of DehydraTECH processed with the glucagon-peptide 1 ("GLP-1") drug, semaglutide, related to its mode of action and performance. more info >> |
|
Tuesday, April 16, 2024 |
|
Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study |
Lexaria Bioscience Corp. (Nasdaq: LEXX; LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces approval has been received from an independent third-party ethics review board, for human pilot study #2 (the "Study"), investigating GLP-1 drugs and DehydraTECH. more info >> |
|
Tuesday, April 2, 2024 |
|
Lexaria Awarded New Patents |
more info >> |
|
Thursday, March 14, 2024 |
|
Lexaria Appoints Nelson Cabatuan as Chief Financial Officer |
Lexaria Bioscience Corp. (Nasdaq: LEXX) (Nasdaq: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the appointment of Nelson Cabatuan, CPA, as Chief Financial Officer (CFO) effective immediately. more info >> |
|
|
|
|
|
|
|
|
 |
Latest Press Releases |
 |
Peapack-Gladstone Financial Corp (NASDAQ: PGC) Second Quarter 2025 Financial Results
Jul 22, 2025 19:44 HKT/SGT
|
|
|
Military Metals Announces Grab Sample Results up to 40.6% Antimony and 106.5 gpt Gold from Stockpile of Historically Mined Material at West Gore Antimony-Gold Project, Nova Scotia
Jul 22, 2025 19:39 HKT/SGT
|
|
|
35th Hong Kong Book Fair attracts some 900,000 visits despite typhoon
Jul 22, 2025 19:22 HKT/SGT
|
|
|
Satellite Direct-to-Device: CaoCao Becomes the World's First to Embed LEO Satellite Communication Services in the Robotaxi Platform
Jul 22, 2025 18:53 HKT/SGT
|
|
|
InfoComm India 2025 Visitor Registration Opens Strong Amidst Surging Demand for AI and Immersive AV
Jul 22, 2025 18:44 HKT/SGT
|
|
|
Mitsubishi Motors to Terminate Its Joint Venture Partnership with Shenyang Aerospace Mitsubishi Motors Engine Manufacturing
Jul 22, 2025 17:00 JST
|
|
|
Capital Markets Malaysia Expands Simplified ESG Disclosure Guide with a GHG Emission Calculator for SMEs
Jul 22, 2025 14:15 HKT/SGT
|
|
|
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets
Jul 22, 2025 13:00 HKT/SGT
|
|
|
Eisai To Present Four-Year Efficacy And Safety Data On Continuous Treatment With Lecanemab At The Alzheimer's Association International Conference 2025
Jul 22, 2025 11:56 JST
|
|
|
ASEAN Ceramics & ASEAN Stone Open Doors this October in Bangkok, Thailand
Jul 22, 2025 10:10 HKT/SGT
|
|
|
Anime Tokyo Station TV Anime "SPYxFAMILY" Special Exhibition
Jul 22, 2025 11:00 JST
|
|
|
ShrimpTech JIRCAS and IMT Engineering Announce Strategic Collaboration to Advance Land-Based Aquaculture
Jul 22, 2025 9:00 JST
|
|
|
EUDR Solution From Source Intelligence Simplifies Deforestation Due Diligence
Jul 22, 2025 00:00 HKT/SGT
|
|
|
Sapient Intelligence Open-Sources Hierarchical Reasoning Model, a Brain-Inspired Architecture that Solves Complex Reasoning Tasks with 27 Million Parameters
Jul 21, 2025 21:00 HKT/SGT
|
|
|
Spacely AI Secures US $1 Million Seed Round to Supercharge Generative AI Design for Architects Worldwide
Jul 21, 2025 20:30 HKT/SGT
|
|
|
|
More Press release >> |
|
|
 |
 |
 |
|
|